Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Oertelt Prigione, Sabine ^a   Parol, Roza ^a   Krohn, Stephan ^a   Preißner, Robert ^a   Regitz Zagrosek, Vera ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOLOGY; CLINICAL RESEARCH; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENDER; HUMAN; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; ONCOLOGY; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT CARE; PUBLICATION; PULMONOLOGY; RHEUMATOLOGY; SEX DIFFERENCE; TREND STUDY; SEX RATIO; STATISTICS;

BIOMEDICAL RESEARCH; FEMALE; HUMANS; MALE; PUBLICATIONS; SEX DISTRIBUTION;

EID: 78149264052     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-70     Document Type: Article

References (32)

1. Legato MJ. Beyond women's health the new discipline of gender-specific medicine. Med Clin North Am 2003, 87:917-937. vii, 10.1016/S0025-7125(03)00063-4, 14621324.
2. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008, 83:1-10. 10.1016/S0074-7742(08)00001-9, 18929073.
3. Goldberg RJ, O'Donnell C, Yarzebski J, Bigelow C, Savageau J, Gore JM. Sex differences in symptom presentation associated with acute myocardial infarction: a population-based perspective. Am Heart J 1998, 136:189-195. 10.1053/hj.1998.v136.88874, 9704678.
4. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992, 152:972-976. 10.1001/archinte.152.5.972, 1580724.
5. Oertelt-Prigione S, Regitz-Zagrosek V. Gender aspects in cardiovascular pharmacology. J Cardiovasc Transl Res 2009, 2:258-266. 10.1007/s12265-009-9114-9, 20560015.
6. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006, 5:425-438. 10.1038/nrd2032, 16672926.
7. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J, Bethke N, Zurbrugg HR, Pregla R, Hetzer R, Regitz-Zagrosek V. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 2004, 110:3270-3275. 10.1161/01.CIR.0000147610.41984.E8, 15533858.
8. Michon F, Tummers M. The dynamic interest in topics within the biomedical scientific community. PLoS One 2009, 4:e6544. 10.1371/journal.pone.0006544, 2721680, 19668345.
9. Correa-De-Araujo R. Serious gaps: how the lack of sex/gender-based research impairs health. J Womens Health (Larchmt) 2006, 15:1116-1122. 10.1089/jwh.2006.15.1116, 17199452.
10. Kim AM, Tingen CM, Woodruff TK. Sex bias in trials and treatment must end. Nature 2010, 465:688-689. 10.1038/465688a, 20535184.
11. NIH NIH Guidelines on the inclusion of women and minorities as subjects in clinical research. 2001, Health UNIo ed.: NIH, NIH.
12. Obias-Manno D, Scott PE, Kaczmarczyk J, Miller M, Pinnow E, Lee-Bishop L, Jones-London M, Chapman K, Kallgren D, Uhl K. The Food and Drug Administration Office of Women's Health: impact of science on regulatory policy. J Womens Health (Larchmt) 2007, 16:807-817. 10.1089/jwh.2006.0135, 17678451.
13. Geller SE, Adams MG, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health (Larchmt) 2006, 15:1123-1131. 10.1089/jwh.2006.15.1123, 17199453.
14. McCandless MHE, Gospodnetić O. Lucene in Action 2008, Manning Publications, Second.
15. Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med 1998, 158:2054-2062. 10.1001/archinte.158.18.2054, 9778206.
16. Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005, 353:671-682. 10.1056/NEJMsa032214, 2805130, 16107620.
17. Demirovic J, Blackburn H, McGovern PG, Luepker R, Sprafka JM, Gilbertson D. Sex differences in early mortality after acute myocardial infarction (the Minnesota Heart Survey). Am J Cardiol 1995, 75:1096-1101. 10.1016/S0002-9149(99)80737-1, 7762492.
18. Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 2009, 169:1762-1766. 10.1001/archinternmed.2009.318, 19858433.
19. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med 2009, 169:1767-1774. 10.1001/archinternmed.2009.332, 19858434.
20. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 2006, 3:131-158. 10.1016/S1550-8579(06)80202-0, 16860272.
21. Postma DS. Gender differences in asthma development and progression. Gend Med 2007, 4:S133-146. 10.1016/S1550-8579(07)80054-4, 18156099.
22. Charney P, Morgan C. Do treatment recommendations reported in the research literature consider differences between women and men?. J Womens Health (Larchmt) 1996, 5:579-584.
23. Merkatz R. Promoting gender analysis in peer-reviewed scientific journals: a call to publishers. J Womens Health (Larchmt) 1996, 5:525-527.
24. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993, 270:2590-2597. 10.1001/jama.270.21.2590, 8230644.
25. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 2005, 165:1363-1369. 10.1001/archinte.165.12.1363, 15983284.
26. Baird KL. The new NIH and FDA medical research policies: targeting gender, promoting justice. J Health Polit Policy Law 1999, 24:531-565.
27. Putting gender on the agenda. Nature 2010, 465:665.
28. Oertelt-Prigione S, Regitz-Zagrosek V. Women's cardiovascular health: prevention is key. Arch Intern Med 2009, 169:1740-1741. 10.1001/archinternmed.2009.353, 19858428.
29. Zucker I, Beery AK. Males still dominate animal studies. Nature 2010, 465:690. 10.1038/465690a, 20535186.
30. Wald C, Wu C. Biomedical research. Of mice and women: the bias in animal models. Science 327:1571-1572. 10.1126/science.327.5973.1571, 20339045.
31. Alexanderson K. An assessment protocol for gender analysis of medical literature. Women Health 1999, 29:81-98. 10.1300/J013v29n02_06, 10427650.
32. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002, 347:1403-1411. 10.1056/NEJMoa021266, 12409542.